Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 May 1;10(9):1954. doi: 10.3390/jcm10091954

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Representative cardiac magnetic resonance findings of patients with obstructive hypertrophic cardiomyopathy, hypertrophic cardiomyopathy with restrictive phenotype, amyloidosis, and Fabry disease. (A) Obstructive HCM with intramural septal LGE. (B) HCM with restrictive physiology (MYH7 variant) with massive septal fibrosis and severe atrial enlargement. (C) Light chain immunoglobulin (AL) amyloidosis with transmural septal LGE. (D) Wild-type transthyretin (ATTRwt) amyloidosis with LGE particularly in the right ventricle and atria. (E) Fabry disease with hypertrophic phenotype and subendocardial LGE at the basal lateral segment of the left ventricle. (F) Fabry disease with mild hypertrophy and intramural LGE at the mid-lateral segment of the left ventricle and apex. HCM: hypertrophic cardiomyopathy; LGE: late gadolinium enhancement.